๐ŸŽ Black Friday: up to 50% off of annual plans
Green Lifescience Co., Ltd. (KOSDAQ:114450)
South Korea flag South Korea ยท Delayed Price ยท Currency is KRW
1,977.00
-103.00 (-4.95%)
At close: Nov 20, 2026

Green Lifescience Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
67,77440,34024,86122,36936,50525,338
Revenue Growth
95.56%62.26%11.14%-38.72%44.07%3.16%
Gross Profit
7,4192,4672,980-2,313-1,356-2,270
Operating Income
5,179204.29376.91-4,643-3,958-4,648
Net Income
5,263110.131,562-16,358-3,526-3,136
Earnings Per Share
-5.7481.18-819.47-176.28-156.79
EPS Growth
--92.93%----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
18,47417,18612,88514,45316,94916,203
Total Debt
8,7946,9925,3724,9336,6247,595
Net Cash (Debt)
9,68010,1947,5139,52010,3248,608
Net Cash Growth
36.39%35.68%-21.08%-7.79%19.93%-1.28%
Net Cash Per Share
-531.08390.48476.93516.22430.42

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
2,333363.85525.49370.02-4,552611.38
Capital Expenditures
-4,212-859.51-780.62-495.69-1,478-3,444
Free Cash Flow
-1,879-495.66-255.13-125.67-6,030-2,832
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
10.95%6.12%11.98%-10.34%-3.72%-8.96%
Operating Margin
7.64%0.51%1.52%-20.76%-10.84%-18.34%
Pretax Margin
7.76%0.27%6.28%-73.13%-7.84%-13.49%
Profit Margin
7.76%0.27%6.28%-73.13%-9.66%-12.38%
FCF Margin
-2.77%-1.23%-1.03%-0.56%-16.52%-11.18%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
7.34514.1620.54---
PS Ratio
0.571.401.291.992.445.98